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doi:10.1016/j.ejvs.2008.02.012Abstract Objectives: The expanding haemodialysis population has lead to increased require-
ment for more complex vascular access. The aim of this study is to present the results of an
extensive series of brachiobasilic arteriovenous fistulae.
Methods: BBAVF were performed using single-stage vein transposition. A retrospective review
of case notes was performed.
Results: One hundred and sixty eight BBAVF were created in 144 patients. This was the first
access procedure in only 30 cases and the fourth or fifth in 30. At 24 h, 165 fistulas (98%) were
patent. One hundred and eleven fistulas (66%) were used for haemodialysis and 57 (34%) were
never used, of which 39 (23%) were due to fistula failure. The cumulative secondary patency at
1, 2 and 3 years was 66%, 50% and 41% respectively. There were 201 complications in 119 pa-
tients (71%), including thrombosis (29%), arm oedema (17%), infection (13%) and arterial steal
syndrome (11%). Ten angioplasties and 48 operative procedures were performed for complica-
tions. Pre-operative ipsilateral subclavian catheter had been placed in 62 cases (37%) and was
associated with poor patency.
Conclusions: BBAVF represents an important option for vascular access with acceptable pa-
tency rates, although complication rates remain significant.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
The population of end stage renal failure patients
dependent on haemodialysis continues to expand as a result
of improved survival of patients on dialysis, the inclusion of
older patients onto dialysis programmes and the fallingper, Transplant Department,
n Road, Leicester LE5 4PW,
90064.
.com (S.J.F. Harper).
ty for Vascular Surgery. Publisheavailability of renal transplants.1 In addition, individual
patients may require patent vascular access for many years
requiring multiple access procedures. The Brescia-Cimino
wrist fistula remains the procedure of choice, followed by
the brachiocephalic arteriovenous fistula (BCAVF) formed
at the elbow.2 However, increasing numbers of patients
require alternative access procedures due to damaged, pre-
viously used or poor calibre superficial veins. In most cases
the next option lies with the transposed brachiobasilic fis-
tula (BBAVF) or a brachioaxillary polytetrafluoroethylene
(PTFE) graft.d by Elsevier Ltd. All rights reserved.
238 S.J.F. Harper et al.The BBAVF was first described in 1976 and has been
increasingly accepted as a viable option for secondary or
tertiary vascular access.3 The basilic vein in the upper arm
has the advantage that as a deep vein it is rarely damaged
by previous venepuncture and it is often of good calibre.
This means however, that the basilic vein must be mobi-
lised and superficialised during fistula formation thus
increasing the complexity of the procedure. It is therefore
accepted that the BBAVF has a higher complication rate
than, for example, the BCAVF.4,5 The brachioaxillary graft
remains a recognised alternative to the BBAVF and there
have been several comparative studies, the majority
reporting similar patency rates for the two tech-
niques.4,6e8 However, lower complication rates are ob-
served in the BBAVF and this is generally thought to
outweigh the advantage that the PTFE graft can be used
immediately without requiring a period of maturation.4,8,9
In currently published studies there remain several
contentious issues surrounding BBAVF formation and main-
tenance itself and significant variation in reported
outcomes. The aim of this paper is to present the results
of a large series of BBAVF in terms of outcome, patency and
complication rates.
Materials and Methods
Brachial artery to transposed basilic vein arteriovenous
fistulas (BBAVF) were performed using a previously
described technique.10 One hundred and sixty eight BBAVFs
were performed in 144 patients over a 10 year period.
Patient demographics are shown in Table 1. All patients
underwent surgical review 6e8 weeks post-operatively
and further review and imaging was instigated at this
time if necessary. Patients were then monitored at haemo-
dialysis for changes in fistula function and referred for
further investigation as required.
BBAVF was the procedure of choice in the absence of
a suitable cephalic vein. This was the first vascular access
procedure in 30 cases, the second in 56, the third in 52 and
the forth or fifth in 30. The left arm was selected in 102
cases. In 34 patients, a range of procedures were per-
formed simultaneously to BBAVF formation. These included
permanent central venous catheter insertion (nZ 19), liga-
tion of pre-existing fistula (nZ 8), parathyroidectomy
(nZ 3), removal of permanent central venous catheter
(nZ 2) and removal of peritoneal dialysis catheter (nZ 2).
Previous placement of an ipsilateral subclavian perma-
nent central venous catheter had been performed in 62
patients (37 per cent). Patients with no identifiable riskTable 1 Patient demographics
Patient demographic




Median systolic BP (mmHg) 139 (102e185)
Mean Serum LDL (mmol/L) 4.9 1.3
Mean Serum Triglycerides (mmol/L) 1.9 1.1factors for venous stenosis underwent clinical evaluation
only. Pre-operative imaging of central and arm veins was
undertaken using contrast venography in 89 patients (53 per
cent) and identified a total of 19 ipsilateral stenoses. Five
patients underwent angioplasty and 3 endoluminal stent
insertion prior to fistula formation. The remaining 11
patients had mild stenoses (<50%) deemed not to require
intervention prior to fistula formation.
Data was collected from patient case notes retrospec-
tively with a mean follow up of 15.9 months. Technical
success was defined as the presence of an audible bruit in
the fistula at 24 h post-operatively. Primary, assisted
primary and secondary patency rates (per cent s.e.m.)
were recorded as defined by the recommended standards
for reporting haemodialysis access and calculated using
Kaplan-Meier survival curves (GraphPad Instat Version 3;
GraphPad Software Inc., San Diego, USA).11 Patient deaths
unrelated to fistula failure and patients who underwent
transplantation were considered lost to follow up. Compli-
cation rates include those that were indications for surgical
or radiological intervention and those leading to fistula
failure.Results
Of the 168 fistulas 165 were patent at 24 h. A further 8
patients (not included in the 168) were found to have ba-
silic veins unsuitable for fistula formation intra-operatively,
thus the procedure abandoned, giving a technical success
rate of 94 per cent.
One hundred and eleven fistulas (66%) were used for
haemodialysis and 57 (34%) were never used. Of those
never used for haemodialysis, 39 (23%) failed prior to
needling, 3 patients received a renal transplant, 7 patients
died and 8 fistulas are currently maturing or remain patent
in pre-dialysis patients. True fistula failures were secondary
to thrombosis (nZ 14), failure to mature (nZ 14) and poor
flows (nZ 2). In addition, 9 maturing fistulas required liga-
tion for infection (nZ 3), arm oedema (nZ 3), aneurysm
(nZ 2) and steal syndrome (nZ 1). The 30 day secondary
patency was 95 per cent with five fistulas failing secondary
to thrombosis (2 cases related to wound infection) and four
requiring early ligation for steal, arm oedema, secondary
haemorrhage and peri-anastomotic infection. The primary
and assisted primary patency rates at 1, 2 and 3 years
were 59 4.0% and 66 4.1%, 38 3.8% and 49 4.8%,
30 5.0% and 39 5.7% respectively. The cumulative
secondary patency at 1, 2 and 3 years was 66 4.1%,
50 4.8% and 41 5.6% respectively (Fig. 1).
The median hospital stay was 5 days (range 2e27). There
were 4 patient deaths within 30 days of surgery all of which
were unrelated to fistula formation. Eighty-three patients
required 120 re-admissions due to complications relating to
their fistula. In total one hundred and nineteen patients (71
per cent) developed two hundred and one complications
(Table 2). Ten post operative upper limb and central vein
angioplasties were performed, five with endoluminal stent
insertion. Thrombolysis was used in one patient, resulting
in the successful declotting of a subclavian vein stent.A
total of 48 further operative procedures were performed
on the brachiobasilic fistulas of 42 patients (Table 3).
Figure 1 Survival curve demonstrating fistula primary pa-
tency, assisted primary patency and secondary patency (num-
ber at risk in parentheses).
Table 2 Fistula complications
Early Late Total (%)
Bleeding 11 10 21 (13)
Wound infection 21 12 33 (19)
Thrombosis 5 43 48 (29)
Collection 8 8 (4)
Steal 8 10 18 (11)
Oedema 17 11 28 (17)
Poor flow 13 13 (8)
Poor maturation 19 19 (11)
Venous hypertension 1 4 5 (3)
Aneurysm 7 7 (4)
Cardiac failure 1 1 (1)
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venous stenosis diagnosed pre-operatively, three are
currently patent following pre-operative angioplasty and
stent insertion (nZ 1), pre-operative angioplasty alone
(nZ 1) and post-operative angioplasty (nZ 1). Theremaining 16 fistulas failed secondary to poor maturation
(nZ 3), thrombosis during maturation (nZ 3), poor flows
(nZ 5), thrombosis while in use for haemodialysis (nZ 4)
and death during maturation (nZ 1).
Bleeding requiring hospital admission occurred in 21
patients (13 per cent). Early post operative haemorrhage
was seen in 11 patients and was managed successfully with
surgical exploration in 6 patients and conservative treat-
ment with local pressure in 4 cases. One patient required
fistula ligation for haemorrhage secondary to wound
infection and dehiscence. Late bleeding from needle
puncture sites occurred in 10 patients, 2 developing a false
aneurysm requiring ligation and 3 developing a significant
haematoma leading to fistula loss.
Thrombosis (including thrombosis secondary to other
complications e.g. infection) was the most common com-
plication occurring in 48 patients (29 per cent). Exploratory
surgery with thrombectomy þ/ fistula revision or angio-
plasty was performed in eight patients and successfully re-
established patency in 4 cases. Three fistulas were
managed successfully with conservative measures by rest-
ing them from needling for 6 weeks.
Wound infection in the early post operative period was
seen in 21 patients (13 per cent), 2 following early revision
surgery. Late wound infection occurred in 12 patients,
11 cases associated with needling sites and one wound
infection following late fistula revision. Fifteen patients
with early infection and 7 patients with late infection were
successfully treated with antibiotics alone. Three fistulas
thrombosed as a result of early infection (two within 30
days post-op) and a further 3 were ligated (two within 30
days post-op), one following secondary haemorrhage and
two at high risk of anastomotic breakdown. Early wound
infection was associated with ultrasound proven collection
in 6 patients and was associated with fistula loss in 2 cases.
Thrombosis occurred in 3 cases of late infection and two
fistulas required ligation following bleeding from a needle
site mycotic false aneurysm.
Arterial steal syndrome was diagnosed in 18 patients (11
per cent) and was an early complication in 8 patients,
requiring early ligation in one case. In regard to late steal
syndrome, fistula revision using proximal fistula plicationwas
performed in 3 cases proving successful in 2 and requiring
subsequent ligation for continued ischaemia in one case.
Successful revision using a distal revascularisatione interval
Table 3 Indications and interventions for fistula complications. Values in parentheses are procedures performed within 30
days following fistula formation
Re-exploration Revision Ligation Thrombect. þ/ revision Angioplasty þ/ stent
Arm oedema 6 (1) 4




Poor flow 5 3
Thrombosis 8
Poor maturation 4 (2) 3 (1)
240 S.J.F. Harper et al.ligation procedure was performed in 2 patients. A further
four fistulas with severe distal ischaemia involving active or
impending tissue loss were ligated without previous revision
and 1withmild steal syndromewasmanaged conservatively.
One case of high output cardiac failure was recorded.
Arm oedema occurred in a total of 28 patients (17 per
cent) and was an early post operative complication in
17 cases. Conservative management was successful in 14
such cases but three patients required fistula ligation (one
within 30 days post-op). In late onset arm oedema a central
vein stenosis was identified in four patients, three
undergoing successful angioplasty and stent insertion and
one undergoing unsuccessful angioplasty alone, eventually
requiring ligation. One patient was found to have basilic
vein stenosis which subsequently occluded and another
subclavian stent thrombosis which was successfully throm-
bolysed. Of the five patients with late onset oedema of
unidentified cause 3 were treated conservatively and
a further 2 required ligation.
Flow rates inadequate for dialysis were identified in 13
patients (8 per cent), 3 patients undergoing angioplasty
þ/ stenting and five undergoing surgical revision. Poor
fistula maturation occurred in 19 patients (11 per cent) and
post-operative angioplasty þ/ stenting was performed in
three cases and surgical revision in four cases.Discussion
The brachiobasilic AVF is increasingly the access procedure
of choice when a superficial arm vein is unavailable.
Reported long term cumulative patency rates are in the
range of 54e90, 38e82 and 43e57 per cent at 1, 2 and 3
years respectively.4,6,12e15 In this large series the second-
ary patency rates were comparable at 66, 50 and 41 per
cent at 1, 2 and 3 years, remaining similar to patency rates
reported after five years experience with BBAVF forma-
tion. In addition, the significantly high number of BBAVF
never used for dialysis remains unchanged despite a consis-
tent 30 day secondary patency of 95%. The early fistula
failure rate of 23 per cent in this study is similar to other
reports (range 8e28%). Asif et al. found that despite an
early failure rate of 28% all but 2 of 86 AVFs, including
BBAVF and PTFE grafts, could be salvaged using a struc-
tured close surveillance program allowing timely interven-
tion.12,16 In a recent series of 75 BBAVFs only 8 per cent
were never used for dialysis as a result of the effectiveuse of salvage angioplasty.12 Interestingly however, this
group found thrombectomy unsuccessful which is
contrary to this present series in which half of thrombec-
tomies performed re-established patency. In contrast,
catheter derived thrombolysis was only used once in this
series, although significant success with this approach
has been reported.17 These findings support the increasing
interest in close fistula surveillance programs.18 In the con-
text of the high rates of stenosis and thrombosis seen in
this study introducing such an approach may be beneficial.
The reported complication rate for BBAVF remains high
at 47e71 per cent and this study concurs with other
studies.12e14,19 However the complication rate for PTFE
grafts is even higher, in the range of 60e100 per cent.
This difference remains the central argument supporting
BBAVF over PTFE grafts as long-term patency rates are
similar.4,6,9,20 In addition, the overall re-operation rate
for PTFE grafts ranges from 45 to 67 per cent,4,9,21 much
higher than the 29 per cent for BBAVF in this study. A
more recent comparative study by Oliver et al. highlighted
in particular the higher risk of infection (BBAVF 2% vs. PTFE
13%) and seroma (BBAVF 0% vs PTFE 6%.) Furthermore, al-
though both types of fistula had similar secondary patency
rates, PTFE grafts had a significantly lower 1 year primary
patency of 50 per cent compared to 77% in BBAVF.4
The reasons for the high early failure and complication
rates associated with BBAVF are multi-factorial. Patient age
and co-morbidity have been shown to have a significant
effect onAVFpatency.22 Themedianpatient age in this series
was 61, with 39 per cent of patients aged 65 or over, reflect-
ing the ageing dialysis population. Interestingly, Kawecka
et al. report significantly better patency rates in PTFE grafts
compared to BBAVF in the over 65 age group, a difference not
seen in younger patients.6 This may relate to poorer quality
autologous veins in older patients. Diabetes is associated
with impaired AVF maturation, increased complications
and lower patency rates.19 The high incidence of diabetes
(34per cent) in this study,may significantly affect BBAVFout-
come. BBAVF formationwas thefirst access procedure in only
18 per cent of patients highlighting that this was commonly
more complex surgery performed on patients at higher risk
of AVF failure. Careful vascular access planning, selective ve-
nous imaging and vein preservation in terms of central cath-
eter avoidance and judicious primary fistula formation are
vital. The rate of ipsilateral subclavian catheter placement
has been reduced from 57 to 37 per cent when compared to
previously published results, although the incidence of
Brachiobasilic Fistula Formation 241pre-operative stenosis remains similar at 10 vs. 11 per
cent.14 In this series pre-operatively diagnosed ipsilateral
stenosis was associated with a patency rate of only 16 per
cent highlighting the significance this has on fistula outcome.
In a study of 99 patients undergoing BBAVF formation risk
factors associated with poor patency were obesity,
increased age, previous fistula formation and previous
subclavian venous catheter insertion.15 Pre-operative as-
sessment of basilic vein quality and calibre using Duplex
ultrasound has been increasingly advocated as a way of im-
proving fistula outcome, particularly in terms of technical
success rate.23
In the light of high complication rates for BBAVF the
impact of technique of forming BBAVF on outcome remains
a contentious issue. In this study the vast majority of BBAVF
were formed with the same single-stage, vein transposition
technique. Hossny et al. found that basilic vein elevation
was associated with a higher rate of complications, in
particular haematoma formation, when compared to vein
transposition but there was no significant difference in
patency.13 It has been proposed that BBAVF should be per-
formed as a two-stage procedure with delayed superficiali-
sation.24 A small comparative study reported a significantly
higher patency rate following a two-stage procedure
although other studies found no significant difference.13,25
This study demonstrates that BBAVF remains an important
option for permanent vascular access. Medium-termpatency
rates remain acceptable within this large series although
complication rates are high and require a significant number
of secondary interventions. Overall results do not appear to
improve significantly with greater experience and this re-
flects the ongoing difficulty in managing complex vascular
access in an increasingly high risk cohort of patients. In this
context, careful access planning, close surveillance and
timely intervention are likely to be of particular importance.
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